Home Your basket
• Total ossicular reconstru...
   Price 10.50 €
• The relationship between ...
   Price 5.50 €
• Drop weld thermal injurie...
   Price 8.50 €
• Interests of multimedia s...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Frontal sinus osteoma com...
   Price 5.50 €
• Difficult blepharoplastie...
   Price 10.50 €
• Exophthalmos arising from...
   Price 10.50 €
• Evaluation of rhinologic ...
   Price 10.50 €
• Cervical lymph node metas...
   Price 8.50 €
• Influence of phonetic con...
   Price 10.50 €
• Interest of the cervical ...
   Price 10.50 €
• Contribution of endoscopi...
   Price 8.50 €
• The use of speech therapy...
   Price 10.50 €
• Life after total laryngec...
   Price 8.50 €
• Newborn and infant nasal ...
   Price 5.50 €
• Migrating esophageal fore...
   Price 5.50 €
• Cataract surgery and its ...
   Price 10.50 €
• Skull vibratory test in p...
   Price 10.50 €
• Bone anchored hearing aid...
   Price 8.50 €
• Tympanoplasty: Experience...
   Price 12.00 €
• Transverse maxillary defi...
   Price 8.50 €
• Attention deficit disorde...
   Price 10.50 €
• Setting up a «Bonebridge»...
   Price 10.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Personality study in prof...
   Price 5.50 €
• Treatment of children wit...
   Price 8.50 €
• Occupational therapy in t...
   Price 8.50 €
• Thyroid papillary microca...
   Price 10.50 €
• Granular cell tumours (Ab...
   Price 8.50 €
• Chronitis tonsillitis...
   Price 8.50 €
• Surgery of mucocele of th...
   Price 10.50 €

Total Order 298.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 1999 o

CERVICO-FACIAL CARCINOLOGY

Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence ?


Authors : G. Dolivet, P. Colosetti, J. L. Merlin, Cl. Depardieu, M. Lapeyre, E. Wattel, J. Sarini, J. Ton Van, L. Geoffrois, Ph. Lagarde (Vandoeuvre les Nancy)

Ref. : Rev Laryngol Otol Rhinol 1999;120,1:5-12.

Article published in french



Summary : The study of epidemiology and of the carcinogenesis in epidermoid carcinomas of the upper aerodigestive tract shows that their occurrence is not random. Tobacco abuse plays a major role, especially because of benzopyrene, mutagen of the P53 gene, however it is associated with many other potentiating factors : alcohol, metals, hydrocarbures, virus, food, climate, genetic fragility that create genetic lesions at the origin of carcinogenesis. The latter occurs as "field cancerization" with multiple alterations of the mucosa and general attack of the control systems of the differentiation, growth and cell apoptosis which usually protect the cell against the phenomena of carcinogenesis. The P53 protein gene, retinoid receptors as well as the system of detoxifying glutathion S transferase are modified at the very early stage of these diseases, these abnormalities can be logically related to epidemiological data. These date lead us therefore to imagine complementary specific reverting therapies of induced genetic abnormalities, through the reexpression of non mutated gene encoding P53 protein and the use of retinoid. These various modalities are reported hereafter.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE